Annett Linge, Shivaprasad Patil, Marianne Grosser, Fabian Lohaus, Kristin Gurtner, Max Kemper, Volker Gudziol, Dominik Haim, Alexander Nowak, Inge Tinhofer, Daniel Zips, Maja Guberina, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Henning Schäfer, Anca-Ligia Grosu, Amir Abdollahi, Jürgen Debus, Ute Ganswindt, Claus Belka, Steffi Pigorsch, Stephanie E Combs, Simon Boeke, Cihan Gani, Korinna Jöhrens, Gustavo B Baretton, Steffen Löck, Michael Baumann, Mechthild Krause
PURPOSE: To assess the robustness of prognostic biomarkers and molecular tumour subtypes developed for patients with head and neck squamous cell carcinoma (HNSCC) on cell-line derived HNSCC xenograft models, and to develop a novel biomarker signature by combining xenograft and patient datasets. MATERIALS AND METHODS: Mice bearing xenografts (n=59) of ten HNSCC cell lines and a retrospective, multicentre patient cohort (n=242) of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG) were included...
December 16, 2023: Radiotherapy and Oncology